Literature DB >> 32429625

Is the achievement of 85% of age-predicted heart ratemax at exercise test sufficient to make diagnosis of myocardial ischemia in athletes?

Annalisa Bosio1, Mauro Borchini2, Claudio Pecci2, Bruno Donatucci1, Matteo Montano1, Ferdinando Iellamo3,4.   

Abstract

BACKGROUND: Exercise test (ET) is a validated tool for the identification of coronary artery disease (CAD) even among athletes. A "cut-off" of 85% HRmax is often chosen as an "end point" although it has been shown that this percentage is far from a maximal effort and might be insufficient to evaluate athletes who often reach HRs close to 100% of the theoretical HRmax during sport activity. The aim of this study was to identify the percentage of theoretical HRmax (% HRmax) at which ST segment depression due to a coronary insufficiency on ECG at ET became significant and how much this value would be different from the "cut-off" of 85% of the theoretical HRmax.
METHODS: Forty-two male competitive athletes of three different sport disciplines (58±7.9 years) tested positive during ET at HRmax greater than 85% with ST depression ≥2 mm from V1 to V6 and / or ≥1 mm from D1 to aVf at J point + 80 ms, were included. ECG traces recorded at 85% of HRmax, were compared with those recorded at the percentage of HRmax corresponding to the significant ST depression (%HRmaxST).
RESULTS: % HRmax at which the ST depression become significant was 93.4±3.4% with a Δ% of + 8.4% compared to 85%. ST segment depression at peak exercise on precordial leads was significantly different from that at 85% HRmax (P<0.0001). TC coronary scan confirmed CAD.
CONCLUSIONS: The cut off of 85% HRmax is insufficient to identify signs of reduced coronary reserve in competitive athletes.

Entities:  

Mesh:

Year:  2020        PMID: 32429625     DOI: 10.23736/S0026-4725.20.05172-5

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN: 0026-4725            Impact factor:   1.347


  1 in total

1.  Diagnostic value of the cardiopulmonary exercise test in coronary artery disease.

Authors:  Ning Li; Jinwen Liu; Yunxia Ren; Jinfang Cheng
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.